SecBot SecBot
144 ·Filed Nov 10, 2026

VCEL

Vericel Corp
NEUTRAL
Impact 2/10
Horizonimmediate Processed6d 11h ago SEC0001959173-26-007917
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The sale is small and routine for a director exercising options. No material signal for the stock. Monitor for any subsequent Form 4 filings to confirm execution and for any pattern of larger insider sales.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$59.03
T+0 close · Nov 10, 2026 · via day close
Latest settled
+0.71%
T+1 · $59.45
Vs SPY
−0.61%
α at T+1
Next horizon
T+5
in 4h
  1. T+0 · Nov 10 $59.03entry
  2. T+1 · 6d ago +0.71%α −0.61% · $59.45
  3. T+4 · todayOpen
  4. T+5 · in 4h Pending
  5. T+20 · in 22d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director Kevin F. McLaughlin filed a Form 144 notice of intent to sell 7,000 shares of Vericel Corp common stock, valued at approximately $408,730 based on the filing date. The shares were acquired through a stock option exercise on November 10, 2026, and the sale is planned for the same day on Nasdaq. This is a relatively small sale relative to the company's $2.8B market cap and the insider's likely holdings, and the filing is routine for a director exercising and selling option shares.

Key Facts

  • Insider: Kevin F. McLaughlin, Director of Vericel Corp
  • Proposed sale: 7,000 shares of common stock
  • Estimated value: $408,730 (based on filing date price of ~$58.39 per share)
  • Shares acquired via stock option exercise on November 10, 2026
  • Sale intended to occur on November 10, 2026 on Nasdaq
  • Broker: Fidelity Brokerage Services LLC
  • Insider's total holdings after sale: 51,029,770 shares (likely a placeholder or total shares outstanding, not McLaughlin's personal holdings)
  • Recent insider activity (30 days): 3 sells totaling $2.1M

Financial Impact

Proposed sale of 7,000 shares worth ~$409K, representing about 0.014% of market cap and a small fraction of the director's likely holdings.

dilutioninsider selling

Risk Factors

  • Form 144 is an intent to sell; the sale may not be executed.
  • The filing does not disclose the insider's total beneficial ownership, so the proportional impact of the sale is unclear.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
86% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-007917
Document: 0001959173-26-007917-index.html0001959173-26-007917
Document: 0001959173-26-007917.txt0001959173-26-007917

Track record

30 reports on VCEL

Performance horizon

1 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +31.08% at T+60 after the May 7, 2026 report. 2 of 4 went positive at some point.

Filters
  1. Nov 13, 20263d ago 144 Neutral 2/10 Entry $56.96 Now $57.48 +0.91% settles Feb 11
  2. Nov 12, 20264d ago Insider Cluster Neutral 3/10 Entry $56.96 Now $57.48 +0.91% settles Feb 11
  3. Nov 12, 20264d ago 144 Neutral 1/10 Entry $57.42 Now $57.48 +0.10% settles Feb 10
  4. Nov 10, 20266d ago 144 Neutral 2/10 Viewing Entry $59.03 Now $57.48 −2.63% settles Feb 8
  5. Nov 9, 20267d ago 144 Neutral 2/10 Entry $59.03 Now $57.48 −2.63% settles Feb 8
  6. Nov 9, 20267d ago 144 Neutral 3/10 Entry $59.03 Now $57.48 −2.63% settles Feb 8
  7. Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $59.03 Now $57.48 −2.63% settles Feb 8
  8. Nov 6, 202610d ago 144 Neutral 2/10 Entry $58.39 Now $57.48 −1.56% settles Feb 5
  9. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $58.39 Now $57.48 −1.56% settles Feb 5
  10. Nov 5, 202611d ago 144 Neutral 2/10 Entry $54.62 Now $57.48 +5.24% settles Feb 4
Showing 10 of 30

US Market Status

Market Closed · Opens in 6h 37m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 10, 2026